2018 Drug Design and Delivery Symposium

We are planning a diverse set of broadcasts for this year’s symposium and will highlight new fields of research exploring new ways to look issues that medicinal chemists are facing. The details for upcoming broadcasts will be posted as they are finalized. 


 
Jan  25  A New Strategy in Drug Discovery: Protac-Induced Protein Degradation
Ian Churcher - BenevolentBio
Aaron Balog - Bristol-Myers Squibb
Feb  22 Women in Drug Discovery and Development: How to Succeed as a Female in Academia and Industry
Annette Bak - AstraZeneca
Donna Huryn - University of Pittsburgh
Erika Araujo - Bristol-Myers Squibb
Nurulain Zaveri - Astraea Therapeutics
Mar 29 A Nanomedicine Overview for mRNA Delivery: Innovative Methods Using Lipid Nanoparticles
Marianna Yanez Arteta - AstraZeneca
Dennis Lueng - Genentech
Apr 26 Nanomaterials for Fighting Antibiotic-Resistant Bacteria
Vincent Rotello - University of Massachusetts at Amherst
Christopher England - American Chemical Society
May 31 Advanced Nano-Delivery Systems: Facilitating Tumor Delivery and Mitigating Resistance
Mansoor Amiji - Northeastern University
Venkat Krishnamurthy - AstraZeneca
Jun 28 Pitfalls and Promise of Central Nervous System Drug Discovery
Valentin Gribkoff - Yale University
Nicholas Meanwell - Bristol-Myers Squibb
Jul 26 How to Optimize Central Nervous System Therapeutics: Med Chem Strategies, Tactics, and Workflows
Craig Lindsley - Vanderbilt Center for Neuroscience Drug Discovery 
Amy Newman - Intramural Research Program, NIH
Sept 20 A Novel Strategy for the Treatment of Chronic Pain: Antagonising PAR2 with a Monoclonal Antibody
Pete Thornton - AstraZeneca
Nurulain Zaveri - Astraea Therapeutics
Oct 18 Central Nervous System Medicinal Chemistry
Nov 29 Special Topic 
ACS Webinars

Meet the Organizers

Annette Bak
AstraZeneca
AAPS 

Nicholas Meanwell
Bristol-Myers Squibb
ACS MEDI Divison

John Morrison
Bristol-Myers Squibb
AAPS

Janice Silverman
American Chemical Society

Co-Produced By